Met Life Investment Management, LLC Spring Works Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 39,387 shares of SWTX stock, worth $1.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,387
Previous 39,387 -0.0%
Holding current value
$1.4 Million
Previous $1.48 Million 14.97%
% of portfolio
0.01%
Previous 0.01%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$36.06 - $47.62 $161,080 - $212,718
4,467 Added 12.79%
39,387 $1.48 Million
Q1 2024

May 14, 2024
BUY
$36.5 - $52.5 $1.27 Million - $1.83 Million
34,920 New
34,920 $1.72 Million
Q4 2023

Feb 14, 2024
BUY
$18.94 - $37.24 $87,805 - $172,644
4,636 Added 15.08%
35,372 $1.29 Million
Q3 2023

May 09, 2024
BUY
$23.12 - $31.38 $276,029 - $374,645
11,939 Added 63.52%
30,736 $710,000
Q2 2023

Apr 29, 2024
BUY
$23.15 - $32.71 $711,538 - $1.01 Million
30,736 New
30,736 $805,000
Q2 2023

Aug 10, 2023
BUY
$23.15 - $32.71 $711,538 - $1.01 Million
30,736 New
30,736 $805,000
Q1 2023

May 09, 2024
BUY
$24.97 - $34.05 $469,361 - $640,037
18,797 New
18,797 $484 Million
Q4 2022

Jun 14, 2023
BUY
$21.73 - $28.72 $400,310 - $529,079
18,422 New
18,422 $479,000
Q3 2022

May 10, 2024
BUY
$24.1 - $39.66 $35,041 - $57,665
1,454 Added 8.57%
18,422 $525,000
Q3 2022

Jun 14, 2023
BUY
$24.1 - $39.66 $443,970 - $730,616
18,422 New
18,422 $525,000
Q3 2022

Mar 22, 2023
BUY
$24.1 - $39.66 $35,041 - $57,665
1,454 Added 8.57%
18,422 $525,000
Q3 2022

Nov 14, 2022
BUY
$24.1 - $39.66 $35,041 - $57,665
1,454 Added 8.57%
18,422 $526,000
Q2 2022

May 10, 2024
BUY
$18.36 - $60.07 $16,285 - $53,282
887 Added 5.52%
16,968 $417,000
Q2 2022

Jun 20, 2023
BUY
$18.36 - $60.07 $311,532 - $1.02 Million
16,968 New
16,968 $417,000
Q2 2022

Mar 22, 2023
BUY
$18.36 - $60.07 $16,285 - $53,282
887 Added 5.52%
16,968 $417,000
Q2 2022

Aug 11, 2022
BUY
$18.36 - $60.07 $16,285 - $53,282
887 Added 5.52%
16,968 $418,000
Q1 2022

May 10, 2024
BUY
$48.97 - $65.46 $787,486 - $1.05 Million
16,081 New
16,081 $907,000
Q1 2022

Jun 20, 2023
BUY
$48.97 - $65.46 $787,486 - $1.05 Million
16,081 New
16,081 $907,000
Q1 2022

Mar 22, 2023
BUY
$48.97 - $65.46 $270,755 - $361,928
5,529 Added 52.4%
16,081 $907,000
Q1 2022

May 12, 2022
BUY
$48.97 - $65.46 $270,755 - $361,928
5,529 Added 52.4%
16,081 $908,000
Q4 2021

Jun 21, 2023
BUY
$53.3 - $75.84 $562,421 - $800,263
10,552 New
10,552 $654,000
Q3 2021

Jun 21, 2023
BUY
$62.66 - $88.26 $661,188 - $931,319
10,552 New
10,552 $669,000
Q2 2021

May 17, 2024
BUY
$67.45 - $85.63 $61,514 - $78,094
912 Added 9.46%
10,552 $869,000
Q2 2021

Mar 22, 2023
BUY
$67.45 - $85.63 $61,514 - $78,094
912 Added 9.46%
10,552 $869,000
Q2 2021

Aug 16, 2021
BUY
$67.45 - $85.63 $61,514 - $78,094
912 Added 9.46%
10,552 $870,000
Q1 2021

May 17, 2024
SELL
$65.1 - $93.59 $1.65 Million - $2.37 Million
-25,280 Reduced 72.39%
9,640 $709,000
Q1 2021

Jun 26, 2023
BUY
$65.1 - $93.59 $627,564 - $902,207
9,640 New
9,640 $709 Million
Q4 2020

Jun 22, 2023
BUY
$48.36 - $77.92 $466,190 - $751,148
9,640 New
9,640 $699,000
Q3 2020

Jun 26, 2023
BUY
$36.14 - $51.99 $348,389 - $501,183
9,640 New
9,640 $459,000
Q2 2020

May 24, 2024
SELL
$22.98 - $48.57 $580,934 - $1.23 Million
-25,280 Reduced 72.39%
9,640 $405 Million
Q2 2020

Jun 26, 2023
BUY
$22.98 - $48.57 $221,527 - $468,214
9,640 New
9,640 $404,000
Q2 2020

Mar 22, 2023
BUY
$22.98 - $48.57 $106,925 - $225,996
4,653 Added 93.3%
9,640 $404,000
Q2 2020

Aug 14, 2020
BUY
$22.98 - $48.57 $106,925 - $225,996
4,653 Added 93.3%
9,640 $405,000
Q1 2020

Jul 12, 2023
BUY
$20.44 - $41.21 $101,934 - $205,514
4,987 New
4,987 $134,000
Q1 2020

Mar 22, 2023
SELL
$20.44 - $41.21 $65,571 - $132,201
-3,208 Reduced 39.15%
4,987 $134,000
Q1 2020

May 15, 2020
SELL
$20.44 - $41.21 $65,571 - $132,201
-3,208 Reduced 39.15%
4,987 $135,000
Q4 2019

Jul 12, 2023
BUY
$17.74 - $39.52 $145,379 - $323,866
8,195 New
8,195 $315,000
Q4 2019

Mar 22, 2023
SELL
$17.74 - $39.52 $181,426 - $404,171
-10,227 Reduced 55.52%
8,195 $315,000
Q4 2019

Feb 14, 2020
BUY
$17.74 - $39.52 $145,379 - $323,866
8,195 New
8,195 $315,000

Others Institutions Holding SWTX

# of Institutions
237
Shares Held
68.9M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email